Announcements
Volume 2 Issue 4 2019
Order by
NULL
Open Access
Review
Inhibition of Glutamine Metabolism as a Therapeutic Approach Against Pancreatic Ductal Adenocarcinoma
X. Fernandes Miguel,
M. Padrón José
J. Mol. Clin. Med. 2019, 2(4), 97–110;
https://doi.org/10.31083/j.jmcm.2019.04.5121
24
Download
54
Views
Open Access
Review
Molecular and immunological rationale for the use of tyrosine kinase inhibitors and immune checkpoint inhibitors in glioblastomas
Dal Bo Michele,
Baboci Lorena,
Toffoli Giuseppe
J. Mol. Clin. Med. 2019, 2(4), 111–123;
https://doi.org/10.31083/j.jmcm.2019.04.4201
9
Download
1
Citations
28
Views
Open Access
Review
Semaphorin-3A and urothelial carcinoma
Vadas Zahava,
Rubinstein Jacob,
Bahouth Zaher,
Halachmi Sarel
J. Mol. Clin. Med. 2019, 2(4), 125–128;
https://doi.org/10.31083/j.jmcm.2019.04.5061
8
Download
25
Views
Open Access
Original Research
Chemosensitivity and survival of non-small cell lung carcinoma patients receiving neoadjuvant therapy depend on the expression of multidrug efflux transporters
Stankovic Tijana,
Stojsic Jelena,
Dragoj Miodrag,
Milovanovic Zorka, ... Bankovic Jasna
J. Mol. Clin. Med. 2019, 2(4), 129–135;
https://doi.org/10.31083/j.jmcm.2019.04.3241
10
Download
29
Views